Pathologists Lancet Kenya - Cancer antigen 125 (CA-125) is a protein that may be found at higher levels in people with certain types of cancer and other health conditions. The CA-125 test
![Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/21/10/006.jpg)
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
![Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure | CFR Journal Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure | CFR Journal](https://assets.radcliffecardiology.com/s3fs-public/article/2021-12/figure1-pathophysiological-role-of.png?VersionId=kX1ktGyy0gux8QsgdDwvS7VBMHbfHFC4)
Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure | CFR Journal
![Optical-based biosensor for detection of oncomarker CA 125, recent progress and current status - ScienceDirect Optical-based biosensor for detection of oncomarker CA 125, recent progress and current status - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003269722002068-ga1.jpg)
Optical-based biosensor for detection of oncomarker CA 125, recent progress and current status - ScienceDirect
![A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1983/nejm_1983.309.issue-15/nejm198310133091503/20130822/images/img_medium/nejm198310133091503_t1.jpeg)
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer | NEJM
![CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice](https://bjgp.org/content/bjgp/71/707/e465/F1.large.jpg)
CA125 test result, test-to-diagnosis interval, and stage in ovarian cancer at diagnosis: a retrospective cohort study using electronic health records | British Journal of General Practice
![Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis](https://www.frontiersin.org/files/Articles/692083/fcvm-08-692083-HTML/image_m/fcvm-08-692083-g001.jpg)
Frontiers | High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis
![PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a41774d54ed2429de098b01664d00db2774149da/6-Figure2-1.png)
PDF] REVIEW OF CARCINOMA ANTIGEN 125 (CA 125) AS A MARKER OF DISEASE PROGRESSION OR RECURRENCE IN CLINICAL TRIALS | Semantic Scholar
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig4_HTML.png)